Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma For Caregivers For Clinicians Communities FAQs For Parents For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch.

Please Log In/Join Now first, and then use this function!

Recruiting

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis - IM101-679

Actualizada: 02 April, 2018   |   ClinicalTrials.gov

¿CONSIDERANDO ESTE ENSAYO?
Imprima esta página y la guía de ensayo para ayudarlo a hablar con su médico.
Use la guía de ensayo para navegar el proceso de participación en un ensayo clínico. Comprenda los factores clave que debe tener en cuenta antes de tomar una decisión y haga preguntas a su equipo de atención médica.
Imprime esta página IM101-679
Descargar la guía

SELECCIONE EL IDIOMA

Detalles del ensayo

  • Género(s)

  • 18+

    Rango de edad

  • Recruiting

Opciones de tratamiento

Brazos del estudio
INTERVENCIÓN ASIGNADA
Abatacept for Rheumatoid Arthritis (RA)
Fármaco: Abatacept

Criterios clave de elegibilidad

Inclusion Criteria: - Participants recently (within the last 24 months before enrollment) diagnosed with established moderate to severe active RA - Participants naïve of abatacept and who, at their physician's discretion, are initiated with abatacept according the German label/SmPC (Summary of product characteristics) Exclusion Criteria: - Participants who are currently included in any interventional clinical trial in RA Other protocol defined inclusion/exclusion criteria could apply

¿Tiene alguna pregunta? Llame 855-907-3286 o Envíenos un correo electrónico

¿Tiene alguna pregunta?
Llame 855-907-3286 o Envíenos un correo electrónico